Medifast, Inc. (MED)

Medifast Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	118	188	724	1,253	2,424	2,301
Market Cap Growth	-29.68%	-74.09%	-42.20%	-48.30%	5.36%	81.55%
Enterprise Value	-44	35	589	1,211	2,284	2,143
Last Close Price	11.44	17.62	67.22	109.01	188.97	172.79
PE Ratio	474.08	89.76	7.29	8.73	14.78	22.37
Forward PE	-	-	13.05	9.03	13.75	19.21
PS Ratio	0.29	0.31	0.68	0.78	1.59	2.46
PB Ratio	0.55	0.89	3.60	8.08	11.97	14.63
P/TBV Ratio	0.55	0.89	3.60	8.08	11.97	14.63
P/FCF Ratio	182.00	11.03	5.13	7.05	40.17	16.52
P/OCF Ratio	16.34	7.67	4.91	6.44	25.64	15.85
PEG Ratio	-	0.55	0.55	0.55	0.55	0.55
EV/Sales Ratio	-	0.06	0.55	0.76	1.50	2.29
EV/EBITDA Ratio	-	1.26	4.22	6.19	10.24	15.48
EV/EBIT Ratio	-	2.30	4.66	6.55	10.56	15.97
EV/FCF Ratio	-	2.08	4.17	6.81	37.85	15.38
Debt / Equity Ratio	0.06	0.08	0.11	0.17	0.16	0.07
Debt / EBITDA Ratio	0.48	0.49	0.15	0.13	0.14	0.08
Debt / FCF Ratio	18.98	0.95	0.16	0.15	0.54	0.08
Asset Turnover	1.54	2.03	3.42	4.47	4.53	3.97
Inventory Turnover	3.74	3.25	3.42	3.07	3.41	4.64
Quick Ratio	3.71	2.53	1.63	0.62	0.65	1.57
Current Ratio	4.45	3.34	2.43	1.58	1.81	2.10
Return on Equity (ROE)	0.12%	1.02%	55.77%	80.31%	91.20%	78.50%
Return on Assets (ROA)	1.52%	3.24%	25.24%	32.33%	40.08%	35.63%
Return on Invested Capital (ROIC)	1.40%	12.37%	116.95%	131.72%	274.89%	1044.12%
Return on Capital Employed (ROCE)	3.10%	7.00%	58.10%	105.40%	94.60%	81.40%
Earnings Yield	0.21%	1.11%	13.72%	11.46%	6.77%	4.47%
FCF Yield	0.55%	9.07%	19.49%	14.19%	2.49%	6.05%
Dividend Yield	-	-	7.36%	6.02%	3.01%	2.62%
Payout Ratio	-	34.19%	73.45%	49.89%	38.93%	51.71%
Buyback Yield / Dilution	-0.27%	-0.39%	3.15%	4.55%	0.31%	2.20%
Total Shareholder Return	-0.27%	-0.39%	10.51%	10.56%	3.32%	4.82%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q